Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Market Cap Question

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jan 17, 2023 4:14pm

123 Views

Post# 35229084

RE:RE:Market Cap Question

rhodiumd wrote:
It's really not that hard to calculate...

There is 216.5 million shares, fully dilluted (including options, warrants, etc...).

216.5 million x 39.5 cents = $85,500,000 <---- Today's market cap

$3 Billion / 216.5 miilion shares = $13.85 per share.

Thanks for the quick reply, rhodiumd. I know how to calculate a MC, but I've seen too many different OS figures. Best to ask someone who feels they have the correct share count.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario